Acromegaly and gigantism are “same disease, different timing”—but on Q-banks, the answer choices are designed to punish vague thinking. If you can’t explain why each distractor is wrong, you don’t really own the concept. Let’s walk through a classic vignette and then do a full answer-choice autopsy the way you should review every endocrine question.
The Clinical Vignette (Q-Bank Style)
A 32-year-old man presents with progressive enlargement of his hands and feet, increasing ring and shoe sizes, and new-onset headaches. He reports excessive sweating and joint pain. Physical exam shows coarse facial features and prognathism. BP is 152/92 mmHg. Labs reveal elevated serum IGF-1. An oral glucose tolerance test fails to suppress growth hormone. MRI shows a pituitary mass.
Question: What is the most likely underlying diagnosis/mechanism?
The Correct Answer: Pituitary somatotroph adenoma causing acromegaly
Why this is acromegaly (not gigantism)
- Acromegaly = excess GH after epiphyseal plate closure
- Results in appositional bone growth and soft tissue enlargement:
- Hands/feet enlargement
- Coarse facial features, frontal bossing, prognathism
- Macroglossia
- Results in appositional bone growth and soft tissue enlargement:
- Gigantism = excess GH before epiphyseal closure
- Predominantly linear growth → extreme height + long limbs
The diagnostic “lock”
- IGF-1 elevated (best screening test)
- Oral glucose tolerance test: glucose should suppress GH in normal physiology
- In acromegaly: GH fails to suppress (or may paradoxically rise)
- Pituitary mass on MRI supports somatotroph adenoma
High-yield associations (Step 1/2 favorites)
Acromegaly increases risk of:
- Cardiomyopathy, arrhythmias, heart failure (major cause of mortality)
- Hypertension
- Insulin resistance / diabetes
- Obstructive sleep apnea
- Colon polyps and colon cancer → colonoscopy screening is often tested
Treatment (big-picture)
- Transsphenoidal resection is first-line for most pituitary adenomas
- Medical therapy:
- Somatostatin analogs (octreotide, lanreotide) ↓ GH release
- GH receptor antagonist (pegvisomant) ↓ IGF-1 production
- Dopamine agonists (cabergoline) can help in some cases
Acromegaly vs Gigantism: One Table to Rule Them All
| Feature | Acromegaly | Gigantism |
|---|---|---|
| Timing | After epiphyseal closure | Before epiphyseal closure |
| Hallmark growth pattern | Enlarged hands/feet, coarse facial features | Extreme height, long limbs |
| Most common cause | Pituitary somatotroph adenoma | Pituitary somatotroph adenoma |
| Best screening test | IGF-1 | IGF-1 |
| Confirmatory test | Failure of GH suppression with oral glucose | Same |
| Key complications | Cardiomyopathy, HTN, DM, OSA, colon polyps | Similar + mass effects |
Now the Real Skill: Systematically Destroying the Distractors
Below are common answer choices that show up in this exact vignette and how to eliminate them.
Distractor 1: Ectopic GHRH production (e.g., small cell lung cancer, bronchial carcinoid)
Why it’s tempting: It can absolutely cause acromegaly-like features.
Why it’s wrong here (most likely):
- The vignette gives a pituitary mass, which strongly suggests a pituitary adenoma.
- With ectopic GHRH, you may see pituitary hyperplasia rather than a discrete adenoma.
- Q-banks often give clues like:
- Known malignancy, weight loss, smoking history
- Imaging showing a lung mass
- Elevated GHRH level (if provided)
High-yield pearl:
Ectopic GHRH → high GH and high IGF-1, but the driver is high GHRH, and pituitary enlargement can be diffuse.
Distractor 2: Prolactinoma
Why it’s tempting: Pituitary tumors are common and can cause headaches.
Why it’s wrong:
- Prolactinoma classically presents with:
- Galactorrhea
- Amenorrhea (women) / decreased libido and infertility (men)
- It does not cause enlarged hands/feet, prognathism, or failure of GH suppression.
- Also: prolactin can be mildly elevated in any pituitary mass due to stalk effect (loss of dopamine inhibition), which is a classic trap.
High-yield pearl:
If prolactin is very high (often >200 ng/mL), think prolactinoma. Mild/moderate elevation can be stalk effect.
Distractor 3: Nonfunctioning pituitary adenoma
Why it’s tempting: Headaches + pituitary mass = “nonfunctioning adenoma.”
Why it’s wrong:
- Nonfunctioning adenomas cause problems from mass effect, not hormone excess:
- Headache
- Bitemporal hemianopsia (optic chiasm compression)
- Hypopituitarism (low pituitary hormones)
- Here we have biochemical hormone excess (high IGF-1, nonsuppressible GH) and classic acromegalic features.
High-yield pearl:
Nonfunctioning adenoma is often a “diagnosis of absence”—no specific hypersecretion syndrome.
Distractor 4: Hypothyroidism (myxedema)
Why it’s tempting: Coarse facial features and weight gain can mimic.
Why it’s wrong:
- Myxedema causes:
- Puffy face, nonpitting edema, dry skin, constipation, bradycardia
- It does not cause:
- Progressive increase in ring/shoe size
- Prognathism
- Elevated IGF-1 or abnormal GH suppression
High-yield pearl:
Coarse features ≠ acromegaly by default—look for growth of acral parts and confirm with IGF-1 / glucose suppression test.
Distractor 5: Paget disease of bone
Why it’s tempting: Enlarged skull, bony changes, headaches, hearing issues.
Why it’s wrong:
- Paget disease is focal disorder of bone remodeling:
- Elevated alkaline phosphatase
- Normal calcium/phosphate (often)
- Bone pain, deformities, hearing loss
- Does not cause soft tissue overgrowth or endocrine lab findings (IGF-1/GH axis).
High-yield pearl:
Paget = bone turnover problem. Acromegaly = GH/IGF-1 systemic overgrowth (bone + soft tissue + metabolic).
Distractor 6: Marfan syndrome
Why it’s tempting: Patients can be very tall; students over-associate “tall” with gigantism.
Why it’s wrong:
- Marfan is a connective tissue disorder:
- Tall, thin, long extremities (arachnodactyly)
- Lens subluxation up and out
- Aortic root dilation
- Gigantism/acromegaly causes broad, thickened features, not lanky habitus.
- Marfan has no elevated IGF-1 and no GH suppression abnormality.
High-yield pearl:
Marfan = dolichostenomelia (long limbs). Gigantism = excess GH before closure.
Distractor 7: Cushing disease (ACTH-secreting pituitary adenoma)
Why it’s tempting: Pituitary mass + hypertension + metabolic syndrome vibes.
Why it’s wrong:
- Cushing disease presents with:
- Central obesity, moon facies, buffalo hump
- Purple striae, proximal muscle weakness
- Glucose intolerance, hypertension
- But the vignette screams GH excess:
- Acral enlargement and prognathism
- Elevated IGF-1 and nonsuppressible GH
High-yield pearl:
Pituitary adenomas are not interchangeable—match the phenotype to the hormone.
Distractor 8: Primary hypothyroidism causing pituitary enlargement
Why it’s tempting: In primary hypothyroidism, high TRH can cause pituitary thyrotroph hyperplasia.
Why it’s wrong here:
- Primary hypothyroidism symptoms dominate (cold intolerance, constipation, fatigue)
- Labs would show high TSH, low T4
- Pituitary enlargement would be hyperplasia, not a discrete adenoma, and it wouldn’t explain elevated IGF-1 or abnormal GH suppression.
High-yield pearl:
Always interpret pituitary imaging alongside peripheral hormone labs—secondary vs primary endocrine problems can look similar on MRI.
USMLE High-Yield Takeaways (What to Memorize)
- Acromegaly vs gigantism depends on epiphyseal closure.
- Best screening test: IGF-1 (stable, reflects GH activity).
- Confirmatory test: Oral glucose suppression—GH should go down; in acromegaly it doesn’t.
- Common cause: Pituitary somatotroph adenoma.
- Think mass effect: headaches ± bitemporal hemianopsia.
- Think complications: cardiomyopathy, OSA, insulin resistance, colon polyps/cancer.
- Know treatments: surgery first; octreotide/lanreotide, pegvisomant, ± cabergoline.
Quick Self-Check (1-minute drill)
If the stem says:
- Increasing shoe/ring size + coarse features → acromegaly
- Very tall child/adolescent → gigantism
And if the labs say: - High IGF-1 + GH not suppressed by glucose → diagnosis confirmed